Home2024-03-15T18:23:52+00:00

THE MID-ATLANTIC BIO ANGELS ® GROUP MABA ®

We invest in exciting life science companies worldwide

Read More

FOR ENTREPRENEURS

Apply for Funding

Review our Investment Criteria and Submit a Funding Application.

Pitch for Feedback

Too early for an investment? Apply to pitch to a panel of our investors for feedback.

FOR INVESTORS

From Our Blog

Sonorous

Summary Sonorous is developing a vascular stent device to be placed into the cerebral sinuses of patients with intrinsic or extrinsic stenosis which causes pulsatile tinnitus (PT). PT is caused by a venous sinus stenosis/stiffening causing hemodynamic turbulent blood flow and high frequency turbulence transmitted to the inner ear as a pulsating sound. Sonorous' vascular stent opens the narrowed vessel and restores blood flow. Documents Sonorous Series A and Investor Update - Q1 2024 Website https://www.sonorousnv.com/

By |March 6th, 2024|Categories: Portfolio Companies|Comments Off on Sonorous


MABA is grateful for the support of our Sponsors

Ask us about becoming a sponsor
Go to Top